Stock Analysis
Diversified Healthcare Trust (DHC) Stock Analysis
Diversified Healthcare Trust (DHC) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Diversified Healthcare Trust (DHC) currently has an AIQ Score of 47/100, indicating a neutral setup. Momentum is the strongest factor at 75/100. Quality is the weakest current factor at 7/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
DHC at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $7.78 |
| AIQ Score | 47/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $1.85B |
| P/E Ratio (TTM) | -6.88 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | -$0.16 |
| Revenue (quarter ended 2026-06-30) | $365.39M |
| Dividend Yield (TTM) | 0.52% |
| Beta | 2.31 |
| Volume | 1.65M |
| 52-week range | $3.92-$9.66 |
| RSI 14 | 65.36 |
| 50-Day SMA | $7.78 |
| 200-Day SMA | $7.76 |
| Analyst Price Target | $9.50 |
| Next Earnings | Nov 2, 2026 |
DHCDiversified Healthcare Trust
Real Estate / REIT - Healthcare Facilities
Low Priority
In Line With Peers
Latest quote
- Momentum75
- Value65
- Quality7
- Risk resilience46
- Sentiment—
DHC Stock Analysis Summary
Diversified Healthcare Trust (DHC) currently has an AIQ Score of 47/100, indicating a neutral setup. Momentum is the strongest factor at 75/100. Quality is the weakest current factor at 7/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, DHC has AIQ Score of 47/100 with Momentum base of 75/100 and fading Quality at 7/100. Wait for component alignment before adding exposure.
Momentum (75/100) leads while Quality (7/100) lags. This cross-factor spread creates entry timing uncertainty.
Real Estate · -2.38% stock move · DHC classified in REIT - Healthcare Facilities.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is DHC Bullish or Bearish Right Now?
DHC currently has a neutral overall setup. Momentum is the strongest factor at 75/100, while Quality is weakest at 7/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 75/100.
- - Price is +2.50% above its 50-day SMA.
- - Analyst target implies +22.11% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (33 vs 9).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
DHC's Technical Analysis Consensus is currently Strong Buy, with 33 buy, 3 neutral, and 9 sell votes. DHC's 14-day RSI is 65.36, which places the stock in a constructive momentum range. DHC's beta is 2.31, indicating greater market sensitivity than the broad market.
What Changed in DHC?
The largest recent change in DHC is Momentum moving up by 10.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the DHC Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
DHC Decision Framework
Public evidence layers, setup checks, and risk context for Diversified Healthcare Trust.
Diversified Healthcare Trust (DHC) Stock Analysis
Diversified Healthcare Trust has an AIQ Score of 47/100 in a Neutral regime. Momentum is strongest at 75/100. Beta is 2.27, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | DHC is in a Neutral AIQ regime with score 47/100. |
| Signal Conflict | The primary conflict is that momentum leads at 75/100 while quality lags at 7/100. |
| Factor Evidence | Momentum 75/100 · Value 65/100 · Quality 7/100 · Risk 46/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 75/100.
Momentum is 75/100 and RSI (14) is 65.4.
DHC is in a Neutral regime at 47/100.
Risk factor is 46/100 with beta 2.27 and annual volatility 38.2%.
Current conflict: momentum leads at 75/100 while quality lags at 7/100.
DHC Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
DHC Fundamentals
DHC valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
DHC Technical Analysis
DHC technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
DHC Stock Catalysts
Track DHC earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
DHC Dividend Analysis
DHC dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
DHC Financial Data
DHC revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
DHC Risk Analysis
DHC volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
DHC Stock News
DHC stock news, market tone, recent headlines, and catalyst context.
DHC vs REITs — Healthcare / Self-Storage / Hotels Peers
Current peer cohort: DHC · DOC · DRH · EXR · GMRE. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| DHC Current stock | 47/100 | 65/100 | 75/100 | 46/100 | 1.84 | 38.20% | Current |
| DOC Healthpeak Properties | 36/100 | 35/100 | 43/100 | 68/100 | 0.26 | 29.39% | DHC vs DOC |
| DRH DiamondRock Hospitality | 67/100 | 67/100 | 79/100 | 75/100 | 2.32 | 26.25% | DHC vs DRH |
| EXR Extra Space Storage | 49/100 | 37/100 | 83/100 | 53/100 | 0.19 | 23.08% | DHC vs EXR |
| GMRE Global Medical REIT | 50/100 | 60/100 | — | 78/100 | 0.42 | 29.45% | DHC vs GMRE |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts3 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching DHC
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for DHC
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
DHC Stock FAQ
What is DHC stock price today?
Diversified Healthcare Trust's current stock price is $7.78. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is DHC bullish or bearish right now?
DHC's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is DHC's market cap?
DHC's market cap is $1.85B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is DHC's current P/E ratio?
DHC's current P/E ratio is -6.88 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is DHC's RSI?
DHC's 14-day RSI is 65.36 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is DHC above its 50-day and 200-day moving averages?
DHC is 2.50% from its 50-day SMA and 2.69% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is DHC's next earnings date?
DHC's next earnings date is currently listed as Nov 2, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does DHC pay a dividend?
DHC's dividend yield is 0.52% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.